Stock Events

Stock Events

Fractyl Health 

$0.46
0
+$0.02+4.78% Today

Statistics

Day High
0.46
Day Low
0.46
52W High
-
52W Low
-
Volume
4
Avg. Volume
-
Mkt Cap
63.68M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

19MayExpected
Q3 2025
Q4 2025
Next
-0.71
-0.53
-0.34
-0.16
Expected EPS
-0.16
Actual EPS
N/A

Financials

-75,732.26%Profit Margin
Unprofitable
2022
2023
2024
186,000Revenue
-140.86MNet Income

Analyst Ratings

$6.00Average Price Target
The highest estimate is 8.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy
67%
Hold
33%
Sell
0%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow GUTS.BOATS. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap116.33B
Medtronic offers products for the diagnosis and treatment of diabetes, competing in the broader metabolic health space.
Abbott Laboratories
ABT
Mkt Cap214.96B
Abbott Laboratories provides a wide range of medical devices, including those for diabetes care, directly competing in the metabolic health sector.
Dexcom
DXCM
Mkt Cap22.71B
DexCom, Inc. specializes in glucose monitoring systems for diabetes management, competing in the diabetes care market.
Insulet
PODD
Mkt Cap22.03B
Insulet Corporation offers innovative insulin delivery systems, competing in diabetes management and care.
Tandem Diabetes Care
TNDM
Mkt Cap945.97M
Tandem Diabetes Care, Inc. designs and manufactures insulin pumps, directly competing in the diabetes management space.
Mannkind
MNKD
Mkt Cap1.72B
MannKind Corporation focuses on inhaled therapeutic products for diabetes, offering alternative diabetes management solutions.
Novo Nordisk
NVO
Mkt Cap217.54B
Novo Nordisk is a leading global healthcare company that focuses on diabetes care products, insulin, and devices.
Sanofi
SNY
Mkt Cap124.45B
Sanofi provides a broad range of insulin and diabetes management solutions, competing in the global diabetes care market.
Merck
MRK
Mkt Cap214.76B
Merck & Co., Inc. offers pharmaceutical products for the treatment of diabetes, competing in the medication aspect of diabetes care.
Bristol-Myers Squibb
BMY
Mkt Cap93.79B
Bristol-Myers Squibb Company engages in the discovery, development, and delivery of medicines for diabetes, among other areas.

About

Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is based in Lexington, Massachusetts.
Show more...
CEO
ISIN
US35168W1036

Listings

XNAS
US
GUTS
BOATS
BOATS
GUTS.BOATS

0 Comments

Share your thoughts

FAQ

What is Fractyl Health stock price today?▼
The current price of GUTS.BOATS is $0.46 USD — it has increased by +4.78% in the past 24 hours. Watch Fractyl Health stock price performance more closely on the chart.
What is Fractyl Health stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Fractyl Health stocks are traded under the ticker GUTS.BOATS.
What is Fractyl Health market cap?▼
Today Fractyl Health has the market capitalization of 63.68M
When is the next Fractyl Health earnings date?▼
Fractyl Health is going to release the next earnings report on May 19, 2026.
What were Fractyl Health earnings last quarter?▼
GUTS.BOATS earnings for the last quarter are -0.31 USD per share, whereas the estimation was -0.18 USD resulting in a -72.22% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Fractyl Health revenue for the last year?▼
Fractyl Health revenue for the last year amounts to 186,000 USD.
What is Fractyl Health net income for the last year?▼
GUTS.BOATS net income for the last year is -140.86M USD.
When did Fractyl Health complete a stock split?▼
Fractyl Health has not had any recent stock splits.